Advanced Functional Brain Imaging
Within the Same-Day Diagnostic Pathway
The Same-Day Diagnostic Pathway is built upon four integrated layers of assessment: structural, cognitive, functional (where clinically indicated), and molecular or biomarker evaluation. Functional brain imaging represents one of these layers within a unified framework for the rigorous assessment of cognitive symptoms.
It is not routinely required for every patient. Rather, it is considered on a case-by-case basis when clinical assessment and structural imaging leave important diagnostic questions unresolved.
These investigations are selected deliberately and interpreted within full clinical context. No scan determines diagnosis in isolation. Clarity emerges through integration.
Structural Imaging — The Foundation
MRI forms the backbone of structural brain imaging in the assessment of cognitive symptoms. It identifies strokes, tumours, inflammation, fluid disturbances, and patterns of atrophy affecting memory-related regions such as the hippocampus. Structural imaging is essential for excluding alternative or treatable causes of cognitive symptoms.
However, MRI reflects anatomical change, often after neuronal injury has occurred. In earlier stages of neurodegenerative disease, structural imaging may appear normal. In such cases, functional molecular imaging may provide additional biological insight.
FDG PET — An Energy Map of the Brain
FDG PET (fluorodeoxyglucose positron emission tomography) is a functional brain scan that measures regional glucose metabolism. Because neurons rely on glucose as their primary fuel, patterns of uptake provide insight into cellular energy function.
Within each neuron are mitochondria, often described as the powerhouses of the cell. They convert glucose into usable energy. In several neurodegenerative conditions, mitochondrial function becomes impaired as part of the disease process, leading to reduced efficiency within affected neural networks.
FDG PET uses a radiolabelled glucose analogue to create an energy map of the brain. Areas of reduced uptake may reflect early network dysfunction before structural change becomes apparent on MRI.
Characteristic patterns can support diagnostic clarification:
- Alzheimer disease — typically posterior temporoparietal regions
- Frontotemporal dementia — frontal or anterior temporal regions
- Lewy body disease — posterior cortical or occipital involvement
Reduced metabolism is not specific to one condition and must always be interpreted alongside clinical findings and structural imaging.
DAT Scan — Dopamine Transporter Imaging
Amyloid PET — Visualising Amyloid Pathology
- If P217 levels are clearly low, further amyloid imaging is usually unnecessary.
- If results are intermediate, amyloid PET can provide visual confirmation.
- If P217 levels are clearly elevated and treatment decisions are being considered, including disease-modifying monoclonal antibody therapies, amyloid PET may help confirm pathological substrate and establish baseline imaging.
Integration Within the Diagnostic Framework
Functional brain imaging is one component of a consultant-led diagnostic process that includes:
- Detailed clinical consultation
- Structured cognitive assessment
- Neurological examination
- Structural imaging
- Blood biomarker evaluation where appropriate
Diagnosis is reached through synthesis across structural, cognitive, functional, and molecular domains. Functional imaging adds biological depth when required, but does not replace clinical judgement.
Technology informs. Clinical judgement integrates. Responsibility remains with the consultant.
About the Author
Dr Soumit Singhai FRCP is a Consultant Geriatrician with specialist expertise in cognitive disorders and dementia. He is the Founder and Clinical Lead of Memory & Brain Clinic London and has been a consultant since 2009. His clinical practice focuses exclusively on the diagnosis and management of memory disorders.
Contact
If you are concerned about cognitive symptoms such as memory or thinking, for yourself or for somebody you care about, you are welcome to get in touch to discuss further by telephone.
Telephone: 0207 062 7248
